Time To Take Profits On Gilead Sciences (Rating Downgrade)
Source: SeekingAlpha
2026-02-20 14:24:17 ET
Shares of Gilead Sciences, Inc. ( GILD ), my favorite in the HIV drugs market, have risen 23.3% since my previous article , " Gilead Sciences: From All-Time Highs To Higher Highs. "...
Read the full article on Seeking Alpha
For further details see:
Time To Take Profits On Gilead Sciences (Rating Downgrade)
Ipsen
NASDAQ: IPSEF
IPSEF Trading
100.0% G/L:
$113.13 Last:
5 Volume:
$0 Open:
IPSEF Latest News
March 09, 2026 02:00:00 am
Ipsen voluntarily withdraws Tazverik® (tazemetostat) in follicular lymphoma and epithelioid sarcoma
February 27, 2026 06:20:11 am
Ipsen receives positive CHMP opinion for Ojemda® for the treatment as monotherapy of children with relapsed or refractory BRAF-altered pediatric low-grade glioma
